Koen Bijvank > Brinkhof > Amsterdam, Netherlands > Lawyer Profile

Brinkhof
Grote Bickersstraat 74-78
1013 KS Amsterdam
Netherlands
Koen Bijvank photo

Work Department

Patent

Position

Partner

Career

Koen Bijvank is qualified both as an attorney at law (‘advocaat’) and as a Dutch and European patent attorney. He specialises in international patent litigation and regularly appears both in the courts and before the European Patent Office. His practice mainly involves patents in the areas of chemistry, pharmaceuticals and life sciences. His high-profile clients include The Broad Institute, Cargill and Eli Lilly.

Koen is the past president of the Dutch Group of the International Association for the Protection of Intellectual Property (AIPPI). He is also the chair of the AIPPI Standing Committee on Patents, and president and co-founder of EPLIT, an association of European patent litigators. In addition, he is a member of the editorial board of BIE, a leading Dutch journal on intellectual property, and a tutor at the Centre for International Intellectual Property Studies in Strasbourg, where he teaches candidates for the qualifying examination for European patent attorneys. 

Languages

English, French, German, Dutch

Memberships

AIPPI; EPLIT.

Education

Master’s degree in organic chemistry of the University of Groningen (1995), as well as a LLM and postgraduate certificate in intellectual property litigation of Nottingham Law School in the UK (2011). Until 2017, Koen was partner at V.O. Patents & Trademarks. 

Lawyer Rankings

Netherlands > Intellectual property: Patents

(Next Generation Partners)

Koen Bijvank – Brinkhof

Brinkhof is frequently tasked with co-ordinating multi-jurisdictional patent disputes, overseeing parallel European and global litigation for clients in the pharmaceutical, electronics and tech and consumer goods sectors. Daan de Lange tackles SEP disputes for telecoms clients and FRAND matters. The team is headed by Richard Ebbink, who handles European Patent Office (EPO) opposition proceedings and parallel national disputes, and Mark van Gardingen, who specialises in pharmaceutical, chemical and biotech patents. Koen Bijvank appears before the courts and the EPO for chemicals and life sciences clients. Jan Pot, who heads the firm’s litigation team, handles appeal and opposition proceedings before the Dutch Supreme Court and EPO.